Dermatology News

Although children with psoriasis are at greater risk for developing various comorbidities than children without psoriasis, obesity is a stronger independent risk factor than psoriasis in comorbidity development, according to recently published study results in JAMA Dermatology.

The FDA granted breakthrough therapy designation to upadacitinib for the treatment of moderate-to-severe atopic dermatitis in adults who are eligible for systemic therapy, according to the drug’s manufacturer.

Myeloablative autologous stem cell transplantation improved long-term clinical outcomes, including overall survival and event-free survival, among patients with diffuse cutaneous systemic sclerosis, according to findings published in the New England Journal of Medicine.

The FDA has approved a topical, high-concentration hydrogen peroxide solution for raised seborrheic keratoses, according to a company press release.

The FDA has approved Xeljanz for the treatment of adult patients with active psoriatic arthritis who have had an inadequate response or intolerance to methotrexate and disease-modifying antirheumatic drugs, according to a company press release.

The FDA has approved the third biosimilar to infliximab, infliximab-qbtx, for all eligible indications of the biologic product, according to a company press release.

SAN DIEGO — The American College of Rheumatology and the National Psoriasis Foundation have presented draft recommendations to be included in their new clinical guideline for the treatment of psoriatic arthritis, which is expected to be published in early 2018.

NEW YORK — While skin and soft tissue infections such as MRSA are decreasing around 3% annually, rates of methicillin-susceptible Staphylococcus aureus, clindamycin and Bactrim resistance are rising, according to a presentation at the Infectious Diseases in Children Symposium.

Exclusive and prolonged breast-feeding during infancy can reduce the risk of eczema in teenagers, according to research published in JAMA Pediatrics.

NEW YORK – C. Buddy Creech, MD, MPH, discussed treating Staphylococcus aureus-related skin and soft tissue infections at the 2017 Infectious Diseases in Children Symposium.